Persistent reduction in renal nerve growth factor mRNA after perindopril treatment of young spontaneously hypertensive rats

Hypertension

Volumn 31, Issue 2, 1998, Pages 678-683

  Charchar, Fadi J ^a   Kapuscinski, Miroslav ^b   Harrap, Stephen B ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

Angiotensin converting enzyme; Bradykinin; Genetics; Nerve growth factor; Sympathetic nervous system

Indexed keywords

ANGIOTENSIN; BRADYKININ B2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; MESSENGER RNA; NERVE GROWTH FACTOR; PERINDOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ESSENTIAL HYPERTENSION; GLOMERULUS FILTRATION RATE; KIDNEY NERVE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE;

EID: 0031884159     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.2.678     Document Type: Article

References (36)

1. Harrap SB, Nicolad J, Doyle AE. Persistent effects on blood pressure and renal hemodynamics following chronic converting enzyme inhibition with perindopril. Clin Exp Plannaml Physiol. 1986;13:753-765.
2. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982;62:347-504.
3. Judy WV, Waunabe AM, Murphy WR, Aprison BS, Yu PL. Sympathetic nerve activity and blood pressure in normotensive backcross rats genetically related to the spontaneously hypertensive rat. Hypertension. 1979;!: 598-604.
4. Saxena PR. Interaction between the renin-angiotensin-aldosterone and sympathetic nervous systems.J Cardiovasc Phannacol. 1992;19:S80-S88.
5. Samani NJ, Brammar WJ, Swales JD. Renal and extra-renal levels of renin mRNA in experimental hypertension. Clin Sei. 1991;80:339-344.
6. Wyss JM, Oparil S, Sripairojthikoon W. Neuronal control of the kidney: contribution to hypertension. Can) Physiol Phamacot. 1992;70:759-770.
7. Lundin S, Ricksten SE, Thoren P. Renal sympathetic activity in spontaneously hypertensive rats and normotensive controls, as studied by three different methods. Ada Physiol Scand. 1984;120:265-272.
8. Harrap SB, Van der Meuve WM, Griffin SA, Macphenon F, Lever AF. Brief ACE inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure in the long-term. Hypertension. 1990;16:603-614.
9. Winterwitz SR, Katholi RE, Oparil S. Role of the renal sympathetic 'nerves in the development and maintenance of hypertension in the spontaneously hypertensive rat. J Clin Invest. 1980;66:971-978.
10. Crozier IG, Teoh R, Kay R, Nicholls MG. Sympathetic nervous system during converting enzyme inhibition. AmJ hied. 1989;87:29S-32S.
11. Creedon D, Tuttle JB. Nerve growth factor synthesis in vascular smooth muscle. Hypertension. 1991;18:730-741.
12. Tutde JB, Etheridge R, Creedon DJ. Receptor mediated stimulation and inhibition of nerve growth factor secretion by vascular smooth muscle. Exp Cell Res. 1993;538:350-361.
13. Jefferson S, Rush R, Zettler C, Frewin DB, Head RJ. The influence of the renin angiotensin system on abnormal expression of nerve growth factor in the spontaneously hypertensive rat. Clin Exp Phanmxol Physiol. 1995;22: 478-480.
14. Korsching S, Thoenen H. Nerve growth factor in sympathetic ganglia and corresponding target organs of the rat: correlation with density of sympathetic innervation. Proc Null Acad Sri U S A. 1983;80:3513-3516.
15. Shelton DL, Reichardt LF. Expression of the nerve growth factor correlates with the density of sympathetic innervation in effector organs. Proc Nat] AcadSdUSA. 1984;81:7951-7955.
16. Heumann R, Korsching S, Scott J, Thoenen H. Relationship between levels of nerve growth factor (NGF) and its messenger RNA in sympathetic ganglia and peripheral target tissue. EMBOJ. 1984;3:3183-3189.
17. De Michèle M, Amenta F. Increase in perivascular noradrenergic nerve density and decrease in acetylcholinesterase-positive sympathetic nerve density in the kidneys of spontaneously hypertensive rats. Clin Exp Hypertens. 1988;A10:1031-1049.
18. Zettler C, Rush RA. Elevated concentrations of nerve growth factor in heart and mesenteric arteries of spontaneously hypertensive rats. Brain Res. 1993;614:15-20.
19. Ueyama T, Hamada M, Hano T, Nishio I, Masuyama Y, Furukawa S. Increased nerve growth factor levels in spontaneously hypertensive rats. J Hypertens. 1992;10:215-219.
20. Donohue SJ, Head RJ, Stitzel RE. Elevated nerve growth factor levels in young spontaneously hypertensive rats. Hypertension. 1989;14:421-426.
21. Falckh PH, Harkin LA, Head RJ. Resistance vessel gene expression of nerve growth factor is elevated in young spontaneously hypertensive rats. JHypcrtcns. 1992;10:913-918.
22. Falckh P, Harkin LA, Head RJ. Nerve growth factor mRNA content parallels altered sympathetic innervation in the spontaneously hypertensive rat. Can Exp Fhannacol Physiol. 1992;19:541-545.
23. Duncan AM, Kladis A, Campbell DJ. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypotension. 1994:23:439-449.
24. O'Sullivan JB, Harrap SB. Resetting blood pressure in spontaneously hypertensive rats: the role of bradykinin. Hypertension. 1995:25:162-165.
25. Kapuscinski M, Charchar FJ, Mitchcll GA, Innés B, Norman TL, Harrap SB. Nerve growth factor gene and hypertension in spontaneously hypertensive rats. J Hypertens. 1996:14:191-197.
26. O'Brien RC, Allen TJ, Cooper ME, Bach L, Jerums G. Glomerular filtration rate in early experimental diabetes. Diabetes Comp. 1988; 2:8-11.
27. Chomczynski CN, Sacchi N. Single-step method of RNA isolation by acid guanidinim thiocyanate-phenol-chloroform extraction. Anal Blochem. 1987;162:156-159.
28. Head RJ. Hypernoradrenergic innervation: its relationship to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat. Blood Vessels. 1989;26:1-20.
29. van Helden DF, Woolridge S. Role of nerves in hypertension. Nahm. 1990;348:118-119.
30. Tarver J, Berkowoitz B, Spector S. Alterations in tyrosine hydroxylase and monoamine oxidase activity in blood vessels. Nature. 1971;231:252-253.
31. Nagatsu T, Ikuta K, Numata Y, Kato T, Sano M, Nagatsu I, Umezawa H, Matsuzaki M, Takeuchi T. Vascular and brain dopamine /3-hydroxylase activity in young spontaneously hypertensive rats. Science. 1976;191: 290-291.
32. Haebara HJ, Ichijima K, Motoyoshi T, Okamoto K. Fluorescence microscopical studies on noradrenaline in the peripheral blood vessels of spontaneously hypertensive rats. Jpn CircJ. 1968:32:1391-1400.
33. Lee R, Triggle GR, Cheung DWT, Coughlin MD. Structural and functional consequences of neonatal sympathectomy on blood vessels in SHR. Hypertension. 1987:10:328-338.
34. Levi-Montalcini R, Dal Toso R, della Valle F, Skaper SD, Leon A. Update on the NGF saga. J Kami Sei. 1995:130:119-127.
35. Zetder C, Rush RA. Elevated concentrations of nerve growth factor in heart and mesenteric arteries of spontaneously hypertensive rats. Brain Res. 1993:614:15-20.
36. Harrap SB. A developmental mechanism involving angiotensin in spontaneously hypertensive rats, din Exp Plunnacol Pliysiol. 1992; 19:19-22.